vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT
· Real-Time Price · USD
20.94
-0.31 (-1.46%)
At close: May 20, 2025, 9:43 AM
vTv Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segment Revenue | 1M |
| Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.67M | 2.67M | 3.28M | 3.72M | 3.98M | 2.57M | 2.54M | 3.31M | 3.48M | 2.39M | 2.63M | 1.83M | 5.35M | 5.72M | 2.22M | 2.24M | 2.16M | 2.04M | 1.07M | 1.7M | 2.45M | 1.99M | 1.77M | 2.39M | 2.39M | 2.07M | 2.16M | 2.74M | 2.25M | 2.94M | 2.57M | 3M | 2.82M | 2.25M | 2.4M | 2.67M | 2.58M | 2.37M | 2.42M | 2.3M | 2M |
| Selling, General, and Administrative Revenue Growth | +37.31% | -18.49% | -11.68% | -6.59% | +54.85% | +0.98% | -23.12% | -5.05% | +45.94% | -9.34% | +43.86% | -65.76% | -6.44% | +157.36% | -0.94% | +3.60% | +6.34% | +90.01% | -36.81% | -30.82% | +23.18% | +12.37% | -26.00% | +0.25% | +15.10% | -3.94% | -21.15% | +21.37% | -23.22% | +14.41% | -14.58% | +6.41% | +25.40% | -6.21% | -10.14% | +3.53% | +8.90% | -1.86% | +5.14% | +15.14% | n/a |
| Research and Development Revenue | 2.83M | 2.23M | 3.22M | 3.44M | 2.63M | 2.14M | 2.82M | 4.69M | 3.94M | 3.96M | 3.06M | 2.21M | 3.13M | 5.4M | 2.38M | 2.44M | 3.1M | 2.53M | 1.77M | 2.51M | 4.2M | 4.41M | 3.66M | 4.23M | 2.82M | 2.8M | 2.7M | 8.59M | 8.94M | 10.07M | 8.99M | 9.62M | 10.96M | 11.1M | 11.16M | 12.15M | 11.34M | 8.95M | 7.16M | 5.7M | 7.78M |
| Research and Development Revenue Growth | +26.68% | -30.71% | -6.25% | +30.91% | +22.87% | -24.29% | -39.80% | +19.00% | -0.55% | +29.75% | +38.55% | -29.62% | -42.00% | +126.78% | -2.26% | -21.46% | +22.45% | +43.33% | -29.53% | -40.32% | -4.58% | +20.28% | -13.36% | +49.82% | +0.79% | +3.78% | -68.61% | -3.90% | -11.17% | +12.00% | -6.59% | -12.20% | -1.25% | -0.59% | -8.10% | +7.18% | +26.70% | +24.96% | +25.55% | -26.67% | n/a |